Skip to main content
. 2026 Sep 11;16:35. doi: 10.25259/JCIS_42_2026

Table 1:

Demographic findings of patients and target SFA CTO lesions

Variables Patients (n=98) Technical Success (n=103) Crossing Failure (n=8) Recoil (n=6) p-value
Age 64.34±10.32 64.43±9.77 59.88±7.2 68.67±10.17 0.2
Male gender (%) 79 (83.7) 87 (84.5) 6 (75) 3 (50) 0.61
Hypertension (%) 55 (56.1) 61 (59.2) 4 (50) 3 (50) 0.72
Hyperlipidemia (%) 28 (28.6) 30 (29.1) 2 (25) 0 (0) 1.0
Diabetes mellitus (%) 48 (49) 48 (46.6) 4 (50) 3 (50) 0.29
Coronary artery disease (%) 51 (52) 55 (53.4) 4 (50) 2 (33.3) 1.00
Smoking (%) 82 (83.7) 87 (84.5) 7 (87.5) 5 (83.3) 1.00
Lesion characteristics (n=117)
  Right SFA (%) 56 (47.9) 50 (48.5) 4 (50) 2 (33.3) 1.00
  Length, cm 14.77±8.62 14.10±8.50 22.45±6.63 17.75±8.48 0.008
  Proximal diameter, mm 4.66±1.01 4.71±0.98 4.37±0.92 4.12±1.43 0.35
  Distal diameter, mm 4.02±1.14 4.03±1.11 4.27±1.38 3.38±1.37 0.56
TASC-II (%)
  Type A 17 (14.5) 17 (16.5) 0 0 0.25
  Type B 36 (30.8) 32 (31) 1 (12.5) 3 (50)
  Type C 64 (54.7) 54 (52.5) 7 (87.5) 3 (50)
  PACSS score (≥3) (%) 35 (29.9) 27 (26.2) 4 (50) 4 (66.7) 0.22
  Kockelkoren score (<7) (%) 87 (74.4) 82 (79.6) 4 (50) 1 (16.7) 0.075
Rutherford (%)
  3 29 (24.9) 25 (24.3) 2 (25) 2 (33.3) 1.00
  4 46 (39.3) 41 (39.8) 3 (37.5) 2 (33.3)
  5 40 (34.2) 35 (34) 3 (37.5) 2 (33.3)
  6 2 (1.7) 2 (1.9) 0 (0) 0 (0)
Antegrade* (n=117) (%) 62 (52.9) 57 (55.3) 3 (37.5) 2 (33.3) 0.47
*

Antegrade is including cross procedures, TASC: Trans-Atlantic Inter-Society Consensus, PACSS: The peripheral artery calcification scoring system, Kockelkoren Score; <7 intimal dominant, ≥7 non-intimal dominant plaque formation. SFA: Superficial femoral artery, CTO: Chronic total occlusion Statistical significance was defined as p < 0.05. Continuous variables are presented as mean ± standard deviation